PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1489959
PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1489959
Asia Pacific Angioplasty Balloons Market is valued approximately at USD 600 million in 2023 and is anticipated to grow with a healthy growth rate of more than 4.52% over the forecast period 2024-2032. Angioplasty balloons are medical tools used in angioplasty procedures to treat blocked or narrowed blood vessels, particularly in the heart and other areas of the body. A catheter with an attached balloon is inserted into the affected artery and inflated at the blockage site, compressing the plaque or fatty deposits to widen the vessel and restore blood flow. This process helps alleviate conditions such as coronary artery disease and peripheral arterial disease, improving overall cardiovascular health. The growing focus on minimally invasive procedures and technological developments is a key trend for the Asia Pacific Angioplasty Balloons Market during the estimated period of 2024-2032. Minimally invasive procedures such as angioplasty are gaining traction among patients due to faster recovery times, reduced scarring, and lower complication risks compared to traditional open-heart surgery.
Factors such as the growing prevalence of cardiovascular diseases, advancements in healthcare infrastructure and a rising coronary and peripheral procedures are primarily attributing to the growth of the Asia Pacific Angioplasty Balloons Market. Asia Pacific market is witnessing a rise in the use of angioplasty balloons as a result of companies in the region making research & development investments to create novel balloons that improve safety, effectiveness, and patient outcomes. Additionally, exponential rise in the geriatric population is likely to fuel the demand of angioplasty balloons as they are prone to cardiovascular diseases, which are projected to bolster market growth. Moreover, positive government initiatives and policies aimed at improving healthcare access and promoting innovative medical technologies are also contributing to the growth of the angioplasty balloons market in the Asia Pacific region. However, high cost associated with the procedure, coupled with the complications associated with angioplasty procedures is expected to stifle Asia Pacific Angioplasty Balloons Market growth between 2022 and 2032.
The key countries considered for the Asia Pacific Angioplasty Balloons Market study includes China, India, Japan, South Korea, Australia and Rest of Asia Pacific. In 2023, China's Angioplasty Balloons Market holds a dominating position with the largest market share and is poised for further growth in the anticipated years. The market is experiencing rapid growth due to the growing awareness among both healthcare providers and patients in China about the benefits of minimally invasive procedures such as angioplasty. This awareness, coupled with a growing acceptance of innovative medical technologies, is boosting the market demand. Also, the rising incidence of cardiovascular diseases, including coronary artery disease and peripheral arterial disease, as well as growing presence of both domestic and international companies in the Chinese angioplasty balloons market are further prompting the demand of the angioplasty balloons across the region. Whereas, the market in India is expected to grow at the fastest rate over the forecast period.